Labiana Pharmaceuticals
Labiana was founded in 1958 specialising in the manufacture of Pharmacological Products for veterinary use. The company was later acquired by the Fine Chemicals division on BASF Group in 1980, meaning the flexibility of the company could be bolstered by the ethic and culture of that famous international Group. In 1999, LABIANA became independent through an MBO (Management Buy Out) while in 2003, the management succesfully organised a Secondary MBO, with changes in the shareholdings. In 2004, LABIANA expanded its pharmaceutical activity with the purchase of the Valeant Group's manufacturing facility at Corbera de Llobregat (Barcelona). In 2007, LABIANA was bought by the Dutch company ATC Corporate Services (Netherlands) B.V. In 2013, LABIANA Life Sciences and LABIANA Pharmaceuticals were bought by 7 Directors that currently are the sole owners of the company. Today, LABIANA Life Sciences and LABIANA Pharmaceuticals develop their commercial activity in the national and international market with own product and third party product, offering integrated outsourcing services for the human and veterinary pharmaceutical industries.
About Labiana Pharmaceuticals
Founded
1949Estimated Revenue
$50M-$100MEmployees
51-250Funding / Mkt. Cap
$7MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
28NAICs Code
32541Location
City
TerrassaState
CataloniaCountry
SpainLabiana Pharmaceuticals
Find your buyer within Labiana Pharmaceuticals